On March 13, 2024, DOWRAB, an anti-rabies vaccine developed by Dow University of Health Sciences, was officially launched, marking a significant milestone. The ceremony, attended by the Honorable Vice Chancellor, Prof. Mohammed Saeed Quraishy T.I., marked the start of a new era in the fight against rabies. Preclinical & Challenge studies of Dow RAB (Anti –Rabies Vaccine), carried out in DIABAR to launch the first Biological product by Dow University of Health Sciences.
Related Posts
Plasma Collection and Processing Laboratory
The Dow Institute for Advanced Biological and Animal Research (DIABAR) is thrilled to announce the inauguration of its new facility,... read more
DIABAR’s commitment towards the research and innovation
DIABAR is committed to publish quality research in esteemed journals, represent the institute at national and international forums and to... read more
DIABAR showcases in Exhibitions
DIABAR participated, won awards/prizes in various national and international conferences and represented the DUHS as a hub of research to... read more